programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
695. UPDATE ON TREATMENT STRATEGIES FOR ANAPLASTIC GLIOMA<br />
G. SIMONETTI, P. GAVIANI, A. BOTTURI, E. LAMPERTI, A. SILVANI (Milano)<br />
696. SUBACUTE CEREBELLAR DEGENERATION WITH ANTI-YO ANTIBODIES<br />
IN A PATIENT WITH OVARIAN CANCER: A CASE REPORT<br />
A. SALMAGGI, A. FIUMANI, L. STANZANI, A. TERRUZZI, B. CICCAGLIONI, C. MANGIONI,<br />
A. PELLEGRINO (Lecco)<br />
697. RADIATION-INDUCED TUMOURS OF MENINGES AND NEUROLOGIC<br />
SEQUELAE IN TUMOR LONG SURVIVORS. CASE REPORT AND REVIEW<br />
OF THE LITERATURE<br />
A. SALMAGGI, F. FIUMANI (Lecco)<br />
698. USE OF CHLOROQUINE IN THE TREATMENT OF GLIOBLASTOMA: A<br />
CASE REPORT<br />
S. RENZI, V. CAMERIERE, G. JORIO, S. BALESTRINI, C. PEROZZI, R. CERQUA, C.<br />
CAGNETTI, G. LAGALLA, L. PROVINCIALI (Ancona)<br />
SCLEROSI MULTIPLA 3<br />
Moderatori<br />
L. DURELLI (Torino) - A. FRANCIA (Roma)<br />
699. CLINICAL AND NEUROPHYSIOLOGICAL EFFECTS OF FAMPRIDINE IN<br />
MULTIPLE SCLEROSIS PATIENTS: A PILOT STUDY<br />
V. CIMINO, C. GILIBERTO, C.G. CHISARI, C. LEONE, S. MESSINA, F. MASUZZO, I.<br />
DI SILVESTRO, F. PATTI, M. ZAPPIA (Catania)<br />
700. NATALIZUMAB IN MULTIPLE SCLEROSIS WITH SPINAL INVOLVEMENT<br />
C. ZECCA, M. CAPORRO, C. KAMM, M. HELDNER, G. RICCITELLI, U. CANDRIAN, M.<br />
ADAMI, C. STAEDLER, C. GOBBI (Lugano - CH, Bern - CH)<br />
701. SUSTAINED DISABILITY IMPROVEMENT ASSOCIATED WITH REDUCED<br />
MRI LESION BURDEN IN NATALIZUMAB-TREATED PATIENTS WITH<br />
MULTIPLE SCLEROSIS<br />
L. PROSPERINI, F. DE ANGELIS, V. BARLETTA, L. AUSILI-CEFARO, G. BORRIELLO, C.<br />
POZZILLI (Roma)<br />
702. RETROSPECTIVE PERSON YEAR STUDY FOR CURRENT STATE OF<br />
PATIENTS RECEIVING GLATIRAMER ACETATE IN CAMPANIA-MOLISE<br />
IN 2012<br />
G. IULIANO, P. BELLANTONIO, R. FANTOZZI, C. FLORIO, D. SPITALERI, G. MANISCALCO<br />
(Salerno, Pozzilli - IS, Napoli, Avellino)<br />
703. PREGNANCY AND FETAL OUTCOMES AFTER PATERNAL EXPOSURE<br />
TO DISEASE MODIFYING DRUGS FOR MULTIPLE SCLEROSIS<br />
M. GIANNINI, E. PISCOLLA, E. PORTACCIO, A. GHEZZI, B. HAKIKI, L. PASTÒ, L.<br />
RAZZOLINI, C. PECORI, L. DE GIGLIO, C. POZZILLI, D. PAOLICELLI, M. TROJANO, M.<br />
MARROSU, F. PATTI, G. MANCARDI, C. SOLARO, R. TOTARO, M. TOLA, G. DE<br />
LUCA, A. LUGARESI, L. MOIOLA, V. MARTINELLI, G. COMI, M. AMATO (Firenze,<br />
Gallarate - VA, Pisa, Roma, Bari, Cagliari, Catania, Genova, L’Aquila, Ferrara,<br />
Chieti, Milano)<br />
704. REGIONAL ANALYSIS OF GRAY MATTER DAMAGE IN AFRICAN-AMERICANS<br />
WITH MULTIPLE SCLEROSIS<br />
M. PETRACCA, R. TEODORESCU, J. HOWARD, L. FLEYSHER, N. OESINGMANN, I. KATZ-<br />
SAND, J. HERBERT, M. INGLESE (Napoli, New York - USA)<br />
5<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
187